Fibulin-1 and fibrinogen in human atherosclerotic lesions

被引:0
作者
W. Scott Argraves
Asashi Tanaka
Elizabeth P. Smith
Waleed O. Twal
Kelley M. Argraves
Daping Fan
Christian C. Haudenschild
机构
[1] Medical University of South Carolina,Department of Regenerative Medicine and Cell Biology
[2] Hachioji Medical Center of Tokyo Medical University,Department of Clinical Laboratory Medicine
[3] University of Maryland School of Medicine,Center for Vascular and Inflammatory Diseases
[4] University of South Carolina,Department of Cell Biology and Anatomy, School of Medicine
[5] George Washington University Medical Center,Department of Pathology
来源
Histochemistry and Cell Biology | 2009年 / 132卷
关键词
Fibulin-1; Fibrinogen; Extracellular matrix; Atherosclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
Fibulin-1 is a fibrinogen-binding blood protein and a component of many extracellular matrices (ECM) including those of blood vessels. In this study, the deposition patterns of fibulin-1 and fibrinogen were examined in human coronary artery atherosclerotic lesions excised by atherectomy from 20 patients. Fibulin-1 deposition was found to be closely overlapping with fibrinogen located within the atherosclerotic lesions and in regions containing fresh thrombi. Pronounced intracellular fibulin-1 immunostaining was apparent in lesion areas rich in macrophages and foam cells, although THP-1 macrophages and foam cells were found not to express fibulin-1. Strong ECM deposition of fibulin-1 was observed in acellular atheromatous and myxomatous regions. By contrast, fibulin-1 was present at relatively low levels in the ECM associated with smooth muscle cells within and outside of lesions and was not detected in sclerotic regions. These results reveal the pattern of fibulin-1 within human atherosclerotic lesions and highlight the potential for fibulin-1, perhaps derived from the blood and acting in conjunction with fibrinogen, to play a role in the etiology and cardiovascular disease progression, particularly with respect to thrombotic aspects of atherosclerosis.
引用
收藏
页码:559 / 565
页数:6
相关论文
共 169 条
[1]  
Abrignani MG(1999)Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes Cardiologia 44 1047-1052
[2]  
Novo G(1990)Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure J Cell Biol 111 3155-3164
[3]  
Di Girolamo A(1991)The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation Experientia 47 22-31
[4]  
Caruso R(1992)Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin J Biol Chem 267 20120-20125
[5]  
Tantillo R(1976)Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts Proc Natl Acad Sci USA 73 3178-3182
[6]  
Braschi A(1989)Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies Arteriosclerosis 9 109-121
[7]  
Braschi GB(1991)Fibrinogen degradation product fragment D increases endothelial monolayer permeability Am J Physiol 261 L283-L289
[8]  
Strano A(1996)Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen Blood 88 2569-2577
[9]  
Novo S(1982)Adsorptive endocytosis of fibrin monomer by macrophages: evidence of a receptor for the amino terminus of the fibrin alpha chain Proc Natl Acad Sci USA 79 4565-4569
[10]  
Argraves WS(2005)Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican Arterioscler Thromb Vasc Biol 25 180-185